Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2026
Optimal management of oligometastatic prostate cancer: current state and future directions.
Journal: Current opinion in oncology
Published: April 01, 2026
Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.
Journal: CA: a cancer journal for clinicians
Published: March 31, 2026
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.
Journal: JCO oncology practice
Published: November 07, 2025
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration.
Journal: The Lancet. Oncology
Published: August 11, 2025
KDM4A promotes NEPC progression through regulation of MYC expression.
Journal: Cancer letters
Published: June 10, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment.
Journal: Prostate cancer and prostatic diseases
Published: June 04, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Journal: European urology
Published: April 23, 2025
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer.
Journal: European urology
Published: January 07, 2025
Last Updated: 09/26/2026